Skip to main content
Featured, Grants and Awards, News, Angela Kashuba
Brittany Jennings
October 30, 2019



Dean Angela Kashuba
Dean Angela Kashuba of UNC’s Eshelman School of Pharmacy (Photo by Jeyhoun Allebaugh/UNC-Chapel Hill).

Each year, the American Society for Clinical Pharmacology & Therapeutics (ASCPT) recognizes individuals who exhibit outstanding science and achievement in clinical pharmacology and translational science.

ASCPT’s awards span clinical pharmacology, translational medicine and therapeutics, and recognize every stage of a career path. This year, UNC Eshelman School of Pharmacy’s Dean Angela Kashuba received the Rawls-Palmer Progress in Medicine Award.

The award was established in 1978 by Dr. W. B. Rawls to further his commitment to continuing medical education and its impact on patient care. The goal of the Rawls-Palmer Progress in Medicine Award is to incorporate the efforts of modern research in patient care and to help bridge the gap between the results of research and its application in patient care, according to the ASCPT.

“From my first ASCPT annual meeting as a postdoctoral fellow, I have been inspired by the Rawls-Palmer award lectures. This award is an incredible honor for me and is shared with all the incredible scientists who I have had the pleasure of working with in my career – it truly takes a village. I am so grateful to Drs. Reynolds and Brouwer for supporting my nomination,” Kashuba said.

Kim Brouwer, associate dean for research and graduate education at the UNC Eshelman School of Pharmacy, helped nominate Kashuba. “Dr. Kashuba uses her knowledge and expertise in HIV pharmacology to positively influence patient care through laboratory and clinical research, publications, book chapters, presentations, interactions with government agencies and non-government organizations, and mentoring. At the UNC Eshelman School of Pharmacy, we are incredibly proud of her work.”

Because of this recognition, Kashuba will be able to present a lecture at the ASCPT Annual Meeting in March that focuses on recent developments in clinical pharmacology.

Second nominee, Kellie Reynolds, with the U.S. Food and Drug Administration said, “Dr. Kashuba is among the most highly regarded researchers in HIV pharmacology. She is one of the leaders in the quest for medications to prevent and cure HIV. Dr. Kashuba translates research into patient care through interactions with government agencies, non-government organizations, and professional societies. Her work with the unique HIV Cure Center brings us closer to solving this global health epidemic. Her high impact manuscripts address complex issues and inspire further work. And, she continues to educate the next generation of scientists and clinicians. Her work will continue to benefit patient care for the foreseeable future.”

Kashuba joined the UNC-Chapel Hill faculty in 1997. She went on to be appointed chair of the School’s Division of Pharmacotherapy and Experimental Therapeutics in 2015, and was recently named the John A. and Margaret P. McNeill, Sr. Distinguished Professor. She also serves as Director of the UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Core.

After obtaining her Bachelor of Science in pharmacy at the University of Toronto, Kashuba completed a general practice residency at Women’s College Hospital and practiced as a critical care pharmacist at Mount Sinai Hospital, in Toronto, Canada. She received her Pharm.D. from the State University of New York at Buffalo and completed postdoctoral pharmacology training at the Clinical Pharmacology Research Center at Bassett Healthcare in Cooperstown, New York.

Latest News


View All
Comments are closed.